Case Report
A 35-yr-old patient suffering from secondary amenorrhea for two years before
she was diagnosed. Secondary amenorrhea occurred after the first normal
vaginal delivery, and it was initially associated with breastfeeding and a
formerly diagnosed thyroid disease. Transvaginal ultrasound confirmed a
tumorous mass of the right ovary. Blood hormone tests detected high serum
inhibin B and Anti-Müllerian hormone levels and high androgen level
with no signs of virilization. Surgical treatment was indicated for a
definitive diagnosis of suspected sex cord-stromal tumor. Right-sided
laparoscopic salpingo-oophorectomy was performed, and the histopathological
analysis confirmed the diagnosis of granulosa cell tumor adult type. The
oncological team recommended adjuvant chemotherapy after the operation, but
the patient did not give an informed consent. One month after surgical
treatment, spontaneous menstrual bleeding occurred with normalization of sex
hormone levels and the menstrual cycle. Nine months after surgical
treatment, the patient was examined again due to secondary amenorrhea.
Ultrasound confirmed a vital intrauterine pregnancy. The pregnancy course
was normal, and the patient had a full-term spontaneous vaginal delivery of
her second child.
Conclusion
Restoration of fertility after a temporary loss due to hormone-secreting
granulosa cell tumor is possible after sparing surgical treatment. The role
of adjuvant chemotherapy is controversial, particularly in patients with
stage I-II disease because of the rarity of this tumor and the absence of
prospective randomized studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.